Navigation Links
Scientific and Technical Evaluation of Pharmaceuticals, Inc. [STEPh, Inc.], Launches New Competitive Intelligence Web Site
Date:5/22/2013

RALEIGH, N.C., May 22, 2013 /PRNewswire/ -- STEPh, Inc., a full service medical communications company, is pleased to announce the launch of their web site ( http://www.stephreports.com ) dedicated to investigational drug reports [STEPh Reports]. 

About STEPh Reports

STEPh Reports are comprehensive critical reviews of drugs in development. 

Each STEPh Report assesses the competitive landscape by individual drug monograph, MOA, clinical trials data, projected launch year, company, and specific key issues.  STEPh Reports are written by individuals with expertise in clinical pharmacology and knowledge of drug development processes.  Reports are reviewed by subject matter experts.  STEPh Reports are updated quarterly and are fully referenced, including links to original source documents.  Complementary features to STEPh Reports include daily and archival news services, pipeline tables, mini reviews of Hot Topics, and links to key resources.  A Q&A service is also available upon request.

STEPh Reports are available for purchase by yearly subscription to the web site.  The service is available also to individuals and sponsors at a nominal charge. 

Other Services Offered by STEPh, Inc.

Medical Writing—manuscripts, abstracts, posters, product monographs, training materials.  STEPh, Inc., has an impeccable track record for manuscript acceptance in peer review journals, and has developed Product Monographs and learning systems to support new product launches.

Medical Information—creation of standard response letters, support for product launches.  The President of STEPh, Inc., Dr. Bauman, is a founding member of the Medical Communications subgroup of DIA and has been a Medical Information practitioner for over 30 years.  He supervised the medical information support for numerous new product launches and coordinated international medical information services.

Competitive Intelligence (CI)—investigational drug reports, individualized primary research, meetings coverage.  The principals at STEPh, Inc., are notable leaders in CI and have practiced this discipline for more than 20 years. 

About STEPh, Inc.

STEPh, Inc., was formed in 2005 by pharmaceutical industry veterans, each with more than 20 years' experience in Medical Affairs departments of large pharma and biotech companies.  Dr. Jay Bauman is former Editor of Hospital Edition of US Pharmacist, invited speaker at SCIP meetings, and accomplished author with more than 30 technical publications.

Contact

Further information about pricing for services can be obtained by contacting STEPh, Inc., as noted below:

Dr. Jay H. Bauman

President, STEPh, Inc.

info@stephreports.com

http://www.stephreports.com

919-818-4942 (cell)

 


'/>"/>
SOURCE Scientific and Technical Evaluation of Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting
2. Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013
3. Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress
4. Boston Scientific Schedule of Major Events and Presentations at Heart Rhythm 2013
5. Kewaunee Scientific Announces CEO Retirement and Appointment of Successor
6. Blue Belt Technologies Announces Formation of Hip Scientific Advisory Board for Development of Next NavioPFS Application for Femoroacetabular Impingement
7. Afraxis Appoints Carmine Stengone President and Chief Executive Officer, and Christopher Rex, Ph.D., Chief Scientific Officer
8. SkelRegen Welcomes Director of Scientific Affairs to Management Team
9. MDA Scientific Conference To Focus On Therapy Development For Neuromuscular Diseases
10. What Will Thermo Fisher Scientific and Life Technologies $14 billion Merger hold for the Top Ten Suppliers of Synthetic Biology Technology and DNA Sequencing Landscape?
11. Kinex Pharmaceuticals Chief Scientific Officer, Dr. David Hangauer, named the American Cancer Societys 2013 Honoree for its Cuisine for a Cure event
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on the ... announced that patient enrollment in its ongoing randomized ... has exceeded 50% of its 24-patient target. Capricor ... the third quarter of 2016, and to report ...
Breaking Medicine Technology:
(Date:6/26/2016)... Orion, Clarkston, Michigan (PRWEB) , ... June 26, ... ... with respect to fertility once they have been diagnosed with endometriosis. These women ... intercourse but they also require a comprehensive approach that can help for preservation ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand ... project," said Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s ... within Final Cut Pro X . Simply select a ProHand generator and drag ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda ... orthodontic treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including ... accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. ...
Breaking Medicine News(10 mins):